selected publications
- LKB1-Dependent Regulation of TPI1 Creates a Divergent Metabolic Liability between Human and Mouse Lung Adenocarcinoma. Cancer discovery. 2023 Academic Article GET IT
-
Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis.
Cancer research.
2022
Academic Article
GET IT
Times cited: 2 -
Role of mTOR As an Essential Kinase in SCLC.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2020
Academic Article
GET IT
Times cited: 9 -
Anthrax toxin receptor 1 is the cellular receptor for Seneca Valley virus.
The Journal of clinical investigation.
2017
Academic Article
GET IT
Times cited: 41 -
Noninvasive Interrogation of DLL3 Expression in Metastatic Small Cell Lung Cancer.
Cancer research.
2017
Academic Article
GET IT
Times cited: 71 -
Histone Code Aberrancies in Small Cell Lung Cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
2017
Editorial Article
GET IT
Times cited: 2 -
Chemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis.
Cancer cell.
2017
Academic Article
GET IT
Times cited: 295 -
Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.
Cell reports.
2016
Academic Article
GET IT
Times cited: 349 -
Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis.
PloS one.
2016
Academic Article
GET IT
Times cited: 40 -
PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 216 -
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.
Science translational medicine.
2016
Academic Article
GET IT
Times cited: 128 -
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.
The Journal of clinical investigation.
2016
Academic Article
GET IT
Times cited: 275 - Drug therapy: Preclinical oncology - reporting transparency needed. Nature reviews. Clinical oncology. 2015 Academic Article GET IT
-
DNA methylation in small cell lung cancer defines distinct disease subtypes and correlates with high expression of EZH2.
Oncogene.
2015
Academic Article
GET IT
Times cited: 163 -
Differential dynamics of extracellular and cytoplasmic domains in denatured States of rhodopsin.
Biochemistry.
2014
Academic Article
GET IT
Times cited: 5 -
Rapamycin rescues ABT-737 efficacy in small cell lung cancer.
Cancer research.
2014
Academic Article
GET IT
Times cited: 49 -
ERK phosphorylation is predictive of resistance to IGF-1R inhibition in small cell lung cancer.
Molecular cancer therapeutics.
2013
Academic Article
GET IT
Times cited: 30 -
Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer.
Molecular cancer.
2013
Academic Article
GET IT
Times cited: 42 -
The cytoplasmic rhodopsin-protein interface: potential for drug discovery.
Current drug targets.
2012
Review
GET IT
Times cited: 5 -
Differential coupling of the human cannabinoid receptors hCB1R and hCB2R to the G-protein G(alpha)i2beta1gamma2.
Neuroscience letters.
2008
Academic Article
GET IT
Times cited: 11